28 Feb

Napo Pharmaceuticals Signs Agreement with Alamo Pharma Services to Launch National Sales Force for Mytesi™

SAN FRANCISCO, CA (February 28, 2017) — Napo Pharmaceuticals, Inc., a company focused on the development and commercialization of proprietary pharmaceuticals for the global marketplace from plants traditionally used in rainforest areas, announces today that it has signed an agreement with Alamo Pharma Services, Inc. for the establishment and management of a national sales team for Mytesi™ (formerly known as Fulyzaq). Mytesi™, launched by Napo in October 2016, is approved by the U.S. FDA for the...

9 Feb

Mission Pharmacal Announces Continued Support of March of Dimes® and Signature Fundraiser, March for Babies®

Mission Pharmacal Company (“Mission”) celebrated the kick off of its 2017 fundraising campaign in support of the March of Dimes Foundation®, and it’s signature fundraiser March for Babies.

7 Feb

Alamo Pharma Services Announces Launch of New Website

Alamo Pharma Services, Inc. (“Alamo”), a leading pharmaceutical commercial solutions provider and member of the Mission Family of Companies, today announced the launch of their updated website AlamoPharmaServices.com.

24 Jan

Mission Pharmacal Invests In Elements of Genius In Advance of Upcoming “Wellnest” Launch

Mission Pharmacal Company announces its investment in the company Elements of Genius and their flagship product Wellnest™.

9 Jan

Mission Pharmacal Business Development Team Returns to J.P. Morgan Healthcare Conference

Today marks the opening of the 35th annual J.P. Morgan Healthcare Conference (“JPM”) in San Francisco, which Mission has attended for the past several years. 

30 Nov

Mission Pharmacal Serves as Platinum Sponsor of March of Dimes Foundation “Nurse of the Year” Awards In New Jersey and Georgia

Mission Pharmacal Company (Mission) served as Platinum Sponsor for two recent March of Dimes Foundation Annual Nurse of the Year (NOTY) Awards events. 

22 Sep

Incidence of Lice and Pesticide-Resistant “Super Lice” Rises in the U.S. As the Nation’s Youth Go Back to School

Anxious parents and school nurses are faced with the annual spike in head lice cases. The good news is that lice can be eliminated with Lycelle.

9 Aug

ProSolus, Inc. Chief Operating Officer Named to PharmaVOICE 100 Most Inspiring People

Juan Mantelle, COO of Mission’s subsidiary ProSolus®, Inc., is named to PharmaVOICE magazine’s 100 most inspiring people in the life sciences.

26 Jul

Mission Pharmacal Expands Dermatology Commitment with the Acquisition of GlyDerm®

Espada Dermatology™, Inc. (Espada) announces the recent purchase of the  GlyDerm® line of skin care products from Lautus Pharmaceuticals, LLC. 

21 Jul

Alamo Pharma Services COO Shares Keys to Successful Pharmaceutical Product Launches at Second Annual Life Sciences Summit

Peter Marchesini, Chief Operating Officer of Alamo Pharma Services®, participates in CBI’s Second Annual Life Sciences Product Launch Summit in Philadelphia.